Zhongchao (ZCMD) Short term Debt (2018 - 2024)

Zhongchao (ZCMD) reported Short term Debt of $483800.0 for Q4 2024, down 14.32% year-over-year from $564652.0 in Q1 2024, and down 14.32% quarter-over-quarter from $564652.0 in Q4 2023.

Zhongchao (ZCMD) Short term Debt (2018 - 2024) Analysis & Trends

Zhongchao (ZCMD) has 4 years of Short term Debt data on file, last reported at $483800.0 in Q4 2024.

  • Short term Debt for Q4 2024 came in at $483800.0, down 14.32% year-over-year; the trailing twelve-month figure through Dec 2024 was $483800.0 (down 14.32% YoY), and the FY2024 annual result was $483800.0, down 14.32% from the prior year.
  • Short term Debt declined to $483800.0 in Q4 2024 per ZCMD's latest filing, from $564652.0 in the prior quarter.
  • Over five years, Short term Debt peaked at $762962.0 in Q4 2022 and troughed at $483800.0 in Q4 2024.
  • A 3-year average of $603804.7 and a median of $564652.0 in 2023 frame the typical range for Short term Debt.
  • The sharpest annual moves came in 2023 and 2024: Short term Debt slipped 25.99% in 2023, then slipped 14.32% in 2024.
  • A 3-year view of Short term Debt shows it stood at $762962.0 in 2022, then fell by 25.99% to $564652.0 in 2023, then decreased by 14.32% to $483800.0 in 2024.
  • Business Quant data shows ZCMD's Short term Debt at $483800.0 in Q4 2024, $564652.0 in Q4 2023, and $762962.0 in Q4 2022.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Veeva Systems 24.83 Bn 17.52 Bn 662.02 Mn
2 BrightSpring Health Services 13.57 Bn 12.69 Bn 482.22 Mn
3 Healthequity 7.20 Bn 6.93 Bn 256.31 Mn
4 Hinge Health 5.42 Bn 5.11 Bn 154.23 Mn
5 10x Genomics 4.46 Bn 3.92 Bn 106.18 Mn
6 Doximity 3.81 Bn 3.06 Bn 125.97 Mn
7 Waystar Holding 3.52 Bn 3.36 Bn 268.04 Mn
8 Privia Health 2.94 Bn 2.57 Bn 595.71 Mn
9 Omnicell 1.76 Bn 1.59 Bn 140.36 Mn
10 Zhongchao - - -

Historic Data

Download Data
DateValue
Dec 31, 2024 483,800.00
Dec 31, 2023 564,652.00
Dec 31, 2022 762,962.00
Dec 31, 2018 727,220.00